Predictors of new-onset diabetic ketoacidosis in patients with moderate to severe COVID-19 receiving parenteral glucocorticoids: A prospective single-centre study among Indian type 2 diabetes patients

BACKGROUND AND AIM: COVID-19 infection predisposes to diabetic ketoacidosis(DKA); whether glucocorticoids enhances this risk is unknown.We aimed to study the occurrence of DKA after initiating glucocorticoids in patients with type 2 diabetes mellitus(T2DM) and moderate-to-severe COVID-19, and identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondal, Sunetra, DasGupta, Riddhi, Lodh, Moushumi, Gorai, Ramprasad, Choudhury, Brojen, Hazra, Arindam Kumar, Ganguly, Arunangshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004476/
https://www.ncbi.nlm.nih.gov/pubmed/33839639
http://dx.doi.org/10.1016/j.dsx.2021.03.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004476/
https://www.ncbi.nlm.nih.gov/pubmed/33839639
http://dx.doi.org/10.1016/j.dsx.2021.03.022

Ejemplares similares